TCL Archive In Brief: ACS to Spend Record $85 Million On Research: AACR To Honor Hanafusa, DeVita, Barbacid March 14, 1986
TCL Archive ASCO Backs Central IRB For Cancer Trials, Stiffens Conflict-of-Interest Policies May 2, 2003
TCL Archive New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years October 26, 2012
TCL Archive CCRAC Approves New Grant Program For Studies Of Cancer Patient Compliance RFA to Be Issued May 16, 1980
